Rare side effects can include dizziness or slight digestive discomfort
A 2015 study by Huang and colleagues in Drug Design, Development and Therapy used a rat alkali-burn model (n=10 per group) and HUVECs treated with BPC-157 at 200800 ng/mL, reporting accelerated wound closure with enhanced granulation tissue, reepithelialization, and dermal remodeling by day 18, alongside increased endothelial migration and vascular tube formation in vitro via ERK1/2 phosphorylation though the abstract does not report numeric % wound closure or p-values
however, its function remains unknown (Fig
From weekly injections to regular infusions, our clinical practitioners can match your wellness goals and nutritional needs to the ideal B12 therapy
For lupus researchers, the LL-37 story provides important lessons
However, most injections deliver between one and three months of relief